Cargando…

Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis

OBJECTIVE: To compare the efficacy of axillary radiotherapy (ART) with that of completion axillary lymph node dissection (cALND) in clinically node-negative breast cancer patients with a positive sentinel lymph node. METHODS: A literature search was performed in PubMed, EMBASE and Cochrane Library b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Min, Liu, Wei-Guang, Zhang, Lei, Jin, Zi-Ning, Li, Zhan, Liu, Cheng, Li, Dong-Bao, Ma, Ying, Zhang, Jing-Wen, Jin, Feng, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2017
Materias:	Meta Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627701/ https://www.ncbi.nlm.nih.gov/pubmed/29063055 http://dx.doi.org/10.1016/j.cdtm.2017.01.005

Ejemplares similares

Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Axillary Downstaging and the Impact of Clinical Axillary Status on Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis
por: Luo, Yunzhao, et al.
Publicado: (2023)

The Treatment of Axillary Odor: A Network Meta-Analysis
por: Sun, Pengfei, et al.
Publicado: (2019)

Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer
por: Ulain, Qurat, et al.
Publicado: (2018)

Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
por: Simons, Janine M., et al.
Publicado: (2019)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005)

Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
por: Fan, Yu-Jia, et al.
Publicado: (2023)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
por: Garcia-Tejedor, Amparo, et al.
Publicado: (2023)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Axillary management still needed for patients with sentinel node micrometastases
por: Cong, Bin-Bin, et al.
Publicado: (2019)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
por: de Boniface, Jana, et al.
Publicado: (2017)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009)

Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
por: Bear, HD
Publicado: (2005)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
por: Houvenaeghel, Gilles, et al.
Publicado: (2018)

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
por: Campbell, Ian, et al.
Publicado: (2023)

Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis
por: Sanvido, Vanessa Monteiro, et al.
Publicado: (2021)

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
por: Si, Jing, et al.
Publicado: (2022)

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
por: Martelli, Gabriele, et al.
Publicado: (2010)

Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer
por: Li, Jianyi, et al.
Publicado: (2015)

Retraction note to: "Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy"
por: Kil, Won Ho, et al.
Publicado: (2015)

Imprint Cytology Predicts Axillary Node Status in Sentinel Lymph Node Biopsy
por: Bell, Zarina, et al.
Publicado: (2010)

Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node
por: Shojaee, Leyla, et al.
Publicado: (2020)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer
por: Li, Peiyong, et al.
Publicado: (2023)

Will early detection of non-axillary sentinel nodes affect treatment decisions?
por: Wärnberg, F, et al.
Publicado: (2002)

Which Patients Need an Axillary Clearance after Sentinel Node Biopsy?
por: Pazaiti, Anastasia, et al.
Publicado: (2011)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis
por: Ram, Rachna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n36qq1g7nidbg5qv1bd7hrdoh2